Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2022-06-23 15:49 Tx date 2022-06-22 |
$ACST
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+165,000 vol |
2,016,215 | |
Filed 2021-11-15 14:26 Tx date 2021-11-12 |
$ACST
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+287,900 vol |
1,851,215 | |
Filed 2020-04-01 15:45 Tx date 2020-03-31 |
$ACST
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+587,000 vol |
1,563,315 | |
Filed 2019-04-15 13:59 Tx date 2019-04-15 |
$ACST
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$448,000
+350,000 vol $1.28 each |
976,315 | |
Filed 2018-07-04 Tx date 2018-07-02 |
$ACST
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+365,515 vol |
626,315 | |
Filed 2017-06-16 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$164,610
+93,000 vol $1.77 each |
198,800 | |
Filed 2017-06-16 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$274,350
+155,000 vol $1.77 each |
||
Filed 2017-06-15 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$109,740
+62,000 vol $1.77 each |
322,800 | |
Filed 2017-06-15 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$274,350
+155,000 vol $1.77 each |
260,800 | |
Filed 2017-04-13 Tx date 2017-04-11 |
$ACST
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-315,000
-15,000 vol $21.00 each |
105,800 | |
Filed 2017-03-01 Tx date 2017-02-24 |
$ACST
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$82,500
+50,000 vol $1.65 each |
120,800 | |
Filed 2016-06-21 Tx date 2016-06-16 |
$APO
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-280,000
-20,000 vol $14.00 each |
70,800 | |
Filed 2016-06-01 Tx date 2016-05-30 |
$APO
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$62,486
+31,400 vol $1.99 each |
90,800 | |
Filed 2015-12-09 Tx date 2013-12-03 |
$APO
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants (Units)
15 - Acquisition or disposition under a prospectus
|
+20,000 vol |
||
Filed 2015-12-09 Tx date 2013-12-03 |
$APO
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants (Units)
15 - Acquisition or disposition under a prospectus
|
+20,000 vol |
20,000 | |
Filed 2015-12-09 Tx date 2013-12-03 |
$APO
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants (Units)
15 - Acquisition or disposition under a prospectus
|
+20,000 vol |
||
Filed 2015-12-09 Tx date 2015-10-15 |
$APO
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants (Units)
37 - Stock split or consolidation
|
-18,000 vol |
||
Filed 2015-12-09 Tx date 2013-12-03 |
$APO
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants (Units)
10 - Acquisition or disposition in the public market
|
$25,000
+20,000 vol $1.25 each |
||
Filed 2015-12-09 Tx date 2015-10-15 |
$APO
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants (Units)
37 - Stock split or consolidation
|
-18,000 vol |
||
Filed 2015-11-03 Tx date 2015-10-15 |
$APO
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
|
-63,000 vol |
7,000 | |
Filed 2015-11-03 Tx date 2015-10-15 |
$APO
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants (Units)
37 - Stock split or consolidation
|
-18,000 vol |
2,000 | |
Filed 2015-11-03 Tx date 2015-10-15 |
$APO
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-534,600 vol |
59,400 | |
Filed 2015-08-11 Tx date 2015-08-11 |
$NTB
Neptune Technologies & Bioressources Inc. |
Lemieux, Pierre
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,256.15
-1,157 vol $1.95 each |
5 | |
Filed 2015-07-17 Tx date 2015-07-16 |
$NTB
Neptune Technologies & Bioressources Inc. |
Lemieux, Pierre
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,135
-6,250 vol $1.62 each |
1,162 | |
Filed 2015-06-17 Tx date 2015-06-15 |
$APO
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
57 - Exercise of rights
|
$4,500
+12,500 vol $0.36 each |
70,000 | |
Filed 2015-06-17 Tx date 2015-06-15 |
$NTB
Neptune Technologies & Bioressources Inc. |
Lemieux, Pierre
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$10,125
+6,250 vol $1.62 each |
7,412 | |
Filed 2015-06-16 Tx date 2015-06-15 |
$NTB
Neptune Technologies & Bioressources Inc. |
Lemieux, Pierre
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-10,125
-6,250 vol $1.62 each |
0 | |
Filed 2015-06-16 Tx date 2015-06-15 |
$APO
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-4,500
-12,500 vol $0.36 each |
0 | |
Filed 2015-06-08 Tx date 2015-06-01 |
$APO
Acasti Pharma Inc. |
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$76,050
+169,000 vol $0.45 each |
594,000 |